- Home
- BCTX vs JFU Comparison
BCTX vs JFU Comparison
Compare BCTX & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- JFU
- Stock Information
- Founded
- BCTX 2014
- JFU 2006
- Country
- BCTX Canada
- JFU China
- Employees
- BCTX N/A
- JFU N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- JFU Finance: Consumer Services
- Sector
- BCTX Health Care
- JFU Finance
- Exchange
- BCTX Nasdaq
- JFU Nasdaq
- Market Cap
- BCTX 14.4M
- JFU 17.1M
- IPO Year
- BCTX N/A
- JFU 2019
- Fundamental
- Price
- BCTX $7.72
- JFU $2.43
- Analyst Decision
- BCTX Strong Buy
- JFU
- Analyst Count
- BCTX 1
- JFU 0
- Target Price
- BCTX $40.00
- JFU N/A
- AVG Volume (30 Days)
- BCTX 92.9K
- JFU 26.7K
- Earning Date
- BCTX 10-28-2025
- JFU 01-01-0001
- Dividend Yield
- BCTX N/A
- JFU N/A
- EPS Growth
- BCTX N/A
- JFU N/A
- EPS
- BCTX N/A
- JFU 0.58
- Revenue
- BCTX N/A
- JFU $42,467,427.00
- Revenue This Year
- BCTX N/A
- JFU N/A
- Revenue Next Year
- BCTX N/A
- JFU N/A
- P/E Ratio
- BCTX N/A
- JFU $4.25
- Revenue Growth
- BCTX N/A
- JFU N/A
- 52 Week Low
- BCTX $6.00
- JFU $1.01
- 52 Week High
- BCTX $294.00
- JFU $3.60
- Technical
- Relative Strength Index (RSI)
- BCTX 40.75
- JFU 67.03
- Support Level
- BCTX $7.28
- JFU $2.31
- Resistance Level
- BCTX $8.82
- JFU $3.25
- Average True Range (ATR)
- BCTX 0.74
- JFU 0.24
- MACD
- BCTX 0.58
- JFU 0.02
- Stochastic Oscillator
- BCTX 60.82
- JFU 42.25
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.